162 related articles for article (PubMed ID: 25547097)
1. Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease.
Maes M; Anderson G
Curr Pharm Des; 2016; 22(8):1074-85. PubMed ID: 25547097
[TBL] [Abstract][Full Text] [Related]
2. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
3. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson G; Jacob A; Bellivier F; Geoffroy PA
Curr Pharm Des; 2016; 22(8):987-1012. PubMed ID: 26654772
[TBL] [Abstract][Full Text] [Related]
4. Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes.
Beischlag TV; Anderson G; Mazzoccoli G
Curr Pharm Des; 2016; 22(8):1033-48. PubMed ID: 26654773
[TBL] [Abstract][Full Text] [Related]
5. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.
Morris G; Carvalho AF; Anderson G; Galecki P; Maes M
Curr Pharm Des; 2016; 22(8):963-77. PubMed ID: 26667000
[TBL] [Abstract][Full Text] [Related]
6. TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease.
Anderson G; Maes M
CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):137-49. PubMed ID: 23844687
[TBL] [Abstract][Full Text] [Related]
7. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism.
Songtachalert T; Roomruangwong C; Carvalho AF; Bourin M; Maes M
Curr Top Med Chem; 2018; 18(19):1704-1715. PubMed ID: 30430940
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer.
Barreto FS; Chaves Filho AJM; de Araújo MCCR; de Moraes MO; de Moraes MEA; Maes M; de Lucena DF; Macedo DS
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):165-180. PubMed ID: 29543650
[TBL] [Abstract][Full Text] [Related]
9. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
[TBL] [Abstract][Full Text] [Related]
10. Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway.
Roomruangwong C; Kanchanatawan B; Carvalho AF; Sirivichayakul S; Duleu S; Geffard M; Maes M
World J Biol Psychiatry; 2018 Apr; 19(3):200-209. PubMed ID: 27427239
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.
Anderson G; Maes M
Curr Psychiatry Rep; 2015 Feb; 17(2):8. PubMed ID: 25620790
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
Anderson G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
[TBL] [Abstract][Full Text] [Related]
13. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
14. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
15. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.
Chaves Filho AJM; Lima CNC; Vasconcelos SMM; de Lucena DF; Maes M; Macedo D
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):234-249. PubMed ID: 28595944
[TBL] [Abstract][Full Text] [Related]
16. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
[TBL] [Abstract][Full Text] [Related]
17. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.
Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
Mol Neurobiol; 2017 May; 54(4):3038-3049. PubMed ID: 27037573
[TBL] [Abstract][Full Text] [Related]
18. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.
Anderson G; Kubera M; Duda W; Lasoń W; Berk M; Maes M
Pharmacol Rep; 2013; 65(6):1647-54. PubMed ID: 24553013
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.
Anderson G; Maes M; Berk M
Adv Protein Chem Struct Biol; 2012; 88():27-48. PubMed ID: 22814705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
